While the latter recalls small- and large-cell carcinomas of other organs and is driven by RB1 and TP53 inactivation [12,13], G3 PanNETs may represent the progression of their lower-grade counterparts, with which they share the landscape of driver genes [14,15]. The gene discussed is TP53; the disease is large cell carcinoma.